Universal Health's stock plummeted 7.71% during Thursday's intraday trading session, following a pre-market decline.

The sharp drop comes after the company released fourth-quarter financial results that missed analyst expectations. Universal Health reported adjusted earnings per share of $5.88, narrowly below the consensus estimate of $5.90, while revenue of $4.486 billion also fell short of the expected $4.502 billion. The company attributed the shortfall to lower-than-expected medical care demand, particularly as subsidies under Affordable Care Act plans expire, which has reduced patient volumes for elective procedures and preventive visits.

Adding to the negative pressure, analysts have raised concerns about weaker underlying demand, policy risks, and overvalued shares. Bank of America Securities maintained a Sell rating on the stock, citing these factors as reasons for an underperform stance despite the company's generally above-expectations full-year 2026 outlook.